Chemotherapeutic and osteonecrosis Patient Reports February 11, 2012
Chemotherapeutic Side Effects Report #4818415-6
Chemotherapeutic side effect was reported by a Consumer or non-health professional from FRANCE on Aug 02, 2005. Female patient, 56 years of age, was diagnosed with breast cancer metastatic, metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, impaired healing, open wound, osteonecrosis
, sinusitis
, surgery
, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, AREDIA. Patient recovered.Chemotherapeutic Side Effects Report #5047988-6
Chemotherapeutic side effect was reported by a Physician from GERMANY on Nov 03, 2004. Female patient, weighting 127.9 lb, was diagnosed with breast cancer metastatic and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: oral surgery, osteomyelitis, osteonecrosis
, periodontitis, pyogenic granuloma, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with DIGITOXIN, MICARDIS, BISOPROLOL FUMARATE, NORVASC, BISPHOSPHONATES, ZOMETA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #4668610-4
Chemotherapeutic side effect was reported by a Physician from on Nov 03, 2004. Female patient, weighting 127.9 lb, was diagnosed with breast cancer metastatic and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: jaw disorder, osteomyelitis, osteonecrosis
, periodontitis, pyogenic granuloma, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with DIGITOXIN, MICARDIS, BISOPROLOL FUMARATE, NORVASC, ZOMETA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #4561514-7
Chemotherapeutic side effect was reported by a Physician from on Jan 19, 2005. Female patient, 80 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: cardiac disorder, osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA. Patient died.Chemotherapeutic Side Effects Report #4668401-4
Chemotherapeutic side effect was reported by a Physician from on Jan 20, 2005. Female patient, 35 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: jaw disorder, malignant neoplasm progression, metastases to bone, metastases to liver, osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, AREDIA. Patient died.Chemotherapeutic Side Effects Report #4668105-8
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 89 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4668702-X
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 79 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Chemotherapeutic Side Effects Report #4960493-8
Chemotherapeutic side effect was reported by a Physician from UNITED KINGDOM on June 17, 2005. Male patient, 79 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, ZOMETA. Patient recovered.Chemotherapeutic Side Effects Report #5113641-3
Chemotherapeutic side effect was reported by a Physician from BRAZIL on Sept 13, 2006. Male patient, 78 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: economic problem, osteonecrosis
, poor personal hygiene, respiratory failure, social problem. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, AREDIA. Patient died.Chemotherapeutic Side Effects Report #4667061-6
Chemotherapeutic side effect was reported by a Consumer or non-health professional from on Feb 02, 2005. Female patient, 78 years of age, was diagnosed with metastases to bone, sinusitis
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone disorder, gingival ulceration, oral surgery, osteonecrosis
, pain in jaw, primary sequestrum, tooth loss. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, AZITHROMYCIN. Patient recovered.Chemotherapeutic Side Effects Report #4668100-9
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4668148-4
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4955500-2
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula
, osteonecrosis
, pain in jaw, tooth disorder
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4970651-4
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula
, osteonecrosis
, pain in jaw, sequestrectomy, tooth disorder
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #5017826-6
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Male patient, 76 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess jaw, bone disorder, fistula
, osteonecrosis
, pain in jaw, sequestrectomy, tooth disorder
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, PREDNISONE, ALKERAN, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4668147-2
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 74 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4668720-1
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Male patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Chemotherapeutic Side Effects Report #4667104-X
Chemotherapeutic side effect was reported by a Physician from on Jan 18, 2005. Female patient, 72 years of age, was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: impaired healing, osteonecrosis
, pain
, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.Chemotherapeutic Side Effects Report #4955272-1
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4970172-9
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #5017726-1
Chemotherapeutic side effect was reported by a Consumer or non-health professional from DENMARK on Dec 15, 2004. Female patient, 72 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: actinomycosis, bone debridement, bone disorder, fistula
, fistula repair, osteonecrosis
, pain in jaw, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA, ALKERAN, PREDNISONE, THALIDOMID. Patient recovered.Chemotherapeutic Side Effects Report #4666111-0
Chemotherapeutic side effect was reported by a Physician from on Dec 14, 2004. Female patient, 71 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: abscess
, abscess jaw, bone debridement, incisional drainage, infection
, osteonecrosis
, primary sequestrum, tooth extraction, wound debridement. Chemotherapeutic dosage: unknown. During the same period patient was treated with AREDIA. Patient recovered.Chemotherapeutic Side Effects Report #5631819-7
Chemotherapeutic side effect was reported by a Physician from AUSTRIA on Feb 12, 2008. Male patient, 69 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone trimming, gingivitis, osteomyelitis, osteonecrosis
, primary sequestrum, sequestrectomy, tooth extraction, toothache, wound dehiscence. Chemotherapeutic dosage: unknown. During the same period patient was treated with TAXOTERE, ZOLADEX, ZOMETA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #4959029-7
Chemotherapeutic side effect was reported by a Physician from AUSTRIA on Feb 06, 2006. Male patient, 69 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone trimming, gingivitis, osteomyelitis, osteonecrosis
, primary sequestrum, sequestrectomy, tooth extraction, toothache, wound dehiscence. Chemotherapeutic dosage: unknown. During the same period patient was treated with TAXOTERE, ZOLADEX, ZOMETA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #4959093-5
Chemotherapeutic side effect was reported by a Physician from AUSTRIA on Feb 06, 2006. Male patient, 69 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone trimming, gingivitis, osteomyelitis, osteonecrosis
, primary sequestrum, sequestrectomy, tooth extraction, toothache, wound dehiscence. Chemotherapeutic dosage: unknown. During the same period patient was treated with TAXOTERE, ZOLADEX, ZOMETA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #5127659-8
Chemotherapeutic side effect was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2006. Female patient, 64 years of age, weighting 121.0 lb, was diagnosed with metastases to bone, herpes zoster, sleep disorder
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone disorder, oral pain, oral soft tissue disorder, osteonecrosis
, pain in jaw, rash pustular, soft tissue infection, swelling, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, VALTREX, AMBIEN. Patient recovered.Chemotherapeutic Side Effects Report #5022351-2
Chemotherapeutic side effect was reported by a Health Professional from NEW ZEALAND on May 29, 2006. Female patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone disorder, impaired healing, infection
, osteonecrosis
, periodontitis, purulent discharge, swelling, tooth extraction, toothache. Chemotherapeutic dosage: unknown. During the same period patient was treated with ATENOLOL, CANDESARTAN, ASPIRIN, METOPROLOL, OMEPRAZOLE, ZOLEDRONATE. Patient recovered.Chemotherapeutic Side Effects Report #5734624-6
Chemotherapeutic side effect was reported by a Consumer or non-health professional from PORTUGAL on May 05, 2008. Female patient, 61 years of age, was diagnosed with breast neoplasm and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: oral disorder, osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.Chemotherapeutic Side Effects Report #5141244-3
Chemotherapeutic side effect was reported by a Consumer or non-health professional from BELGIUM on Oct 19, 2006. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with HORMONES, ZOMETA. Patient recovered.Chemotherapeutic Side Effects Report #4668719-5
Chemotherapeutic side effect was reported by a Health Professional from on Feb 24, 2005. Male patient, 58 years of age, was diagnosed with multiple myeloma
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: bone debridement, osteomyelitis, osteonecrosis
, pain
, tooth extraction. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI, ZOLEDRONIC ACID. Patient recovered.Chemotherapeutic Side Effects Report #5144920-1
Chemotherapeutic side effect was reported by a Health Professional from BRAZIL on Oct 17, 2006. Female patient, 56 years of age, weighting 189.6 lb, was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.Chemotherapeutic Side Effects Report #4668102-2
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 56 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4668149-6
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Male patient, 56 years of age, was diagnosed with plasmacytoma and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with PAMIDRONATE DI. Patient recovered.Chemotherapeutic Side Effects Report #4728104-4
Chemotherapeutic side effect was reported by a Consumer or non-health professional from ITALY on July 18, 2005. Female patient, 56 years of age, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: aseptic necrosis bone, jaw disorder, osteolysis, osteonecrosis
. Chemotherapeutic dosage: unknown. During the same period patient was treated with FENTANYL CITRATE, HERCEPTIN, DELTACORTENE, COUMADIN, AREDIA. Patient was hospitalized. Patient recovered.Chemotherapeutic Side Effects Report #4668703-1
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 52 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Chemotherapeutic Side Effects Report #4668701-8
Chemotherapeutic side effect was reported by a Health Professional from on May 10, 2004. Female patient, 43 years of age, was diagnosed with breast cancer
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: osteonecrosis
, sequestrectomy. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Chemotherapeutic Side Effects Report #5110442-7
Chemotherapeutic side effect was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2006. Female patient, weighting 121.0 lb, was diagnosed with metastases to bone, herpes zoster, sleep disorder
and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: oral pain, osteonecrosis
, pain in jaw, tooth extraction, tooth infection. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA, VALTREX, AMBIEN. Patient recovered.Chemotherapeutic Side Effects Report #5032883-9
Chemotherapeutic side effect was reported by a Health Professional from UNITED STATES on June 09, 2006. Female patient, weighting 121.0 lb, was diagnosed with metastases to bone and was treated with Chemotherapeutic. After drug was administered, patient experienced the following side effects: infection
, osteonecrosis
, pain in jaw. Chemotherapeutic dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.
Chemotherapeutic and osteonecrosis 